MedCap AB (publ)
STO:MCAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MedCap AB (publ)
STO:MCAP
|
SE |
|
G
|
Gold Pacific Co Ltd
KOSDAQ:038530
|
KR |
|
A
|
Amgen Inc
DUS:AMG
|
US |
|
Budimex SA
F:FBF
|
PL |
|
ANK Bashneft' PAO
MOEX:BANEP
|
RU |
|
Glanbia PLC
OTC:GLAPF
|
IE |
|
Waskita Beton Precast Tbk PT
IDX:WSBP
|
ID |
|
U
|
United Airlines Holdings Inc
BMV:UAL
|
US |
|
R
|
RA Global Services Inc
OTC:RAGL
|
US |
|
8
|
8x8 Inc
DUS:EGT
|
US |
Intrinsic Value
Is MCAP undervalued or overvalued?
See the intrinsic value estimate for MedCap AB (publ) and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MCAP looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with MCAP’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What MedCap AB Does
MedCap AB (publ) is a Swedish healthcare investment company that owns and develops small, specialized businesses in medical technology, diagnostics, and pharmaceuticals. Its portfolio companies sell products such as surgical tools, diagnostic tests, and other healthcare supplies used by hospitals, clinics, laboratories, and other care providers.
- Headquarters
- Sweden SE
- Employees
- 637
- IPO date
- Jul 4, 2006
MedCap has a wide economic moat
MedCap AB (publ) possesses a wide economic moat, providing strong and durable advantages that protect its market position and profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
MedCap AB (publ)
Earnings Waterfall
MedCap AB (publ)
The intrinsic value for MedCap AB (publ) (MCAP) under the Base Case is hidden SEK.
Compared with the current market price of 600.5 SEK, the stock appears hidden.